| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Aveanna Healthcare Holdings Inc. Common Stock
$9.05
+0.1 (+1.12%)
Market Cap
1.97 B
EPS
1.20
P/E Ratio
7.54 $
Value Trade
13.87 M
SEC Financials
Q3 2026Dilution Risk
Revenue
670.48 M
Total Assets
2.11 B
Total Liabilities
1.82 B
Equity
287.28 M
-2.79 %
Week
-3.1 %
1 Month
21.64 %
3 Month
15.58 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
97.20 M
Monthly Burn
-
Runway
-
Burn Trend
StableSEC Filing
Aug 13, 2026
Overview
Volume
3.70 M
52 Week Range
5.93 - 10.32
% held by Insiders
54.22 %
% held by Institutions
36.15 %
Enterprise Value
3.18 B
Total Shares
217.76 M
Short %
5.25 %
Float Shares
84.16 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in AVAH
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
AVAH Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-12-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-12-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-12-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-AVAH
Aug 13, 2026▲ +1.1%today
Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance
Aveanna Healthcare Holdings reported strong financial results for the second quarter of 2026, with revenue reaching $670.5 million, a 13.7% increase compared to the previous year. Net income also saw significant growth, rising to $40.3 million. The company has raised its full-year revenue and adjusted EBITDA guidance, reflecting confidence in its operational strategies and market position.
Read more →-AVAH
Jul 23, 2026Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. has announced the release date for its second quarter earnings, set for August 13, 2026. Following the earnings release, a conference call will be held at 10:00 a.m. ET. Investors can access the call via phone or webcast, with a replay available shortly after the event.
Read more →-AVAH
Jun 2, 2026Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance
Aveanna Healthcare Holdings has completed the acquisition of Family First Homecare for $175.5 million, enhancing its pediatric home care services across seven states. The acquisition is expected to contribute an additional $70 million in revenue and $10 million in Adjusted EBITDA for the fiscal year 2026. Aveanna has updated its guidance to reflect this positive impact, indicating strong growth potential and strategic expansion.
Read more →-AVAH
May 28, 2026Aveanna Healthcare Announces Successful Debt Repricing
Aveanna Healthcare announced the successful repricing of its first lien and revolving credit facilities, resulting in a 50 basis point reduction in interest rates. An additional reduction of 25 basis points is possible with a favorable credit rating. The CFO expressed confidence in the company's operational excellence and strategic growth plans.
Read more →-AVAH
May 28, 2026Investor Contact Matt Buckhalter Chief Financial Officer ir@aveanna.com
Aveanna Healthcare Holdings Inc. announced the successful repricing of its first lien credit facility and revolving credit facility, achieving a 50 basis point reduction in interest rate margins. An additional 25 basis points reduction is possible upon receiving a satisfactory credit rating. Chief Financial Officer Matt Buckhalter expressed confidence in the financing partners and indicated that this move supports ongoing strategic growth initiatives. This repricing is expected to strengthen Aveanna's balance sheet and provide further operational flexibility.
Read more →-AVAH
May 15, 2026Investor Presentation May 2026 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information purpo
Aveanna Healthcare Holdings Inc. provided an investor presentation outlining disclaimers and forward-looking statements. The presentation emphasizes that the information is for informational purposes only and does not constitute an offer or recommendation to purchase securities. It also stresses that certain statements are forward-looking and dependent on various assumptions, which may not hold true. Risks associated with these statements include challenges in executing growth strategies and uncertainties in future performance.
Read more →-AVAH
May 14, 2026▲ +9.9%on this newsshared move
Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance
Aveanna Healthcare Holdings reported strong financial results for Q1 2026, with revenue reaching $647.9 million, a 15.9% increase year-over-year. Net income surged to $41.7 million compared to $5.2 million in the prior year. The company also raised its full-year revenue and adjusted EBITDA guidance, reflecting positive operational trends and growth potential.
Read more →-AVAH
May 12, 2026Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference
Aveanna Healthcare Holdings Inc. will participate in the William Blair 46th Annual Growth Stock Conference on June 2, 2026. The management team is scheduled to present at 2:40 PM CST and will conduct one-on-one investor meetings. Interested parties can access a live webcast of the presentation through the company's Investor Relations website.
Read more →-AVAH
Apr 28, 2026Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
Aveanna Healthcare Holdings Inc. will participate in the Barclays 30th Annual Leveraged Finance Conference in Austin, TX on May 19, 2026. The management team will host one-on-one investor meetings, showcasing the company's commitment to investor engagement. Aveanna provides a wide range of healthcare services across 38 states.
Read more →-AVAH
Apr 23, 2026Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. has announced the release date for its first quarter 2026 earnings, scheduled for May 14, 2026. A conference call will follow at 10:00 a.m. ET, allowing investors to engage directly with the company. The call will be accessible via phone and webcast, with a replay available shortly after.
Read more →-AVAH
Mar 19, 2026▼ -8.2%on this news
Investor Presentation March 2026 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information pur
The investor presentation from Aveanna Healthcare Holdings Inc. outlines various disclaimers and forward-looking statements regarding the company's financial position and strategies. It emphasizes that the information is for informational purposes only and should not be considered an offer to buy securities. Significant risks and uncertainties are acknowledged that may affect the company's future performance. The presentation also highlights that past performance is not indicative of future results, underscoring the variability in business forecasts.
Read more →-AVAH
Mar 19, 2026▼ -8.2%on this news
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS • Fourth Quarter Revenue was $662.5 million, a 27.4% increase over the prior year period • Fourth Quarter Net income
Aveanna Healthcare Holdings reported strong financial results for the fourth quarter and full year 2025, with significant growth in revenue and net income. Fourth quarter revenue reached $662.5 million, marking a 27.4% increase year-over-year, while net income soared to $178.8 million compared to $29.2 million previously. The company maintained its revenue and adjusted EBITDA guidance for 2026 amid its ongoing strategic transformation. Additionally, Aveanna announced an agreement to acquire Family First Homecare, which will expand its service offerings in pediatric home care.
Read more →-AVAH
Mar 12, 2026AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO ACQUIRE FAMILY FIRST HOMECARE Atlanta, Georgia (
Aveanna Healthcare Holdings has announced an agreement to acquire Family First Homecare, a pediatric home care provider with 27 locations across several states. This acquisition aims to enhance Aveanna's specialized care model and expand its geographic footprint. Both companies' leadership expressed confidence in the cultural fit and shared mission of providing high-quality care. The transaction is expected to close in the second fiscal quarter of 2026, though it faces customary closing conditions and potential operational risks.
Read more →-AVAH
Feb 26, 2026Aveanna Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. has announced the release date for its fourth quarter and full year 2025 earnings, set for March 19, 2026. The announcement includes details about a conference call scheduled for the same day at 10:00 a.m. Eastern Time. Investors can access the call via phone or webcast, with a replay available afterward.
Read more →-AVAH
Feb 20, 2026AVEANNA HEALTHCARE, LLC Name: Title: EXECUTIVE Name
Aveanna Healthcare has entered into a new employment agreement with Jeffrey Shaner, continuing his tenure as CEO. The agreement, effective from February 17, 2026, replaces a prior contract from December 2016. The terms include a base salary of $750,000, eligibility for annual bonuses, and equity compensation, ensuring continuity in leadership for the company.
Read more →-AVAH
Feb 11, 2026Aveanna’s Heartways Program Receives CHAP Disease Program Certification
Aveanna Healthcare's Heartways program has achieved CHAP Disease Program Certification for Heart Failure, reflecting its commitment to high-quality care standards. This certification indicates that Aveanna meets rigorous evaluation criteria, enhancing patient outcomes through comprehensive education and symptom management. The program aims to reduce hospitalizations and improve quality of life for patients with heart disease.
Read more →-AVAH
Jan 14, 2026▲ +10%on this news
Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance
Aveanna Healthcare Holdings has announced updated guidance for fiscal year 2025 and initial guidance for 2026. The company aims to provide a broad range of healthcare services to complex patient populations. However, the financial data presented is preliminary and subject to change, highlighting the volatility in their financial reporting.
Read more →-AVAH
Nov 7, 2025Investor Presentation November 2025 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information
Aveanna Healthcare Holdings Inc. released an investor presentation outlining disclaimers and forward-looking statements regarding its future prospects. The presentation emphasizes that the information is for informational purposes only and does not serve as an investment offer or recommendation. It highlights the firm’s reliance on various internal and external data sources while stressing the potential inaccuracies of these projections. Risks associated with executing business strategies, regulatory changes, and financial obligations are also noted.
Read more →-AVAH
Nov 6, 2025▼ -6.3%on this newsshared move
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER FINANCIAL RESULTS AND REVISED 2025 OUTLOOK • Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year period • Third Quarter Net inc
Aveanna Healthcare Holdings announced its third quarter financial results, showing significant growth in revenue and net income compared to the previous year. Third Quarter Revenue reached $621.9 million, a 22.2% increase, and net income improved to $14.1 million from a loss of $42.8 million. The company also raised its full-year 2025 revenue guidance to over $2.375 billion and adjusted EBITDA guidance to over $300 million, showcasing strong business momentum. The integration of Thrive Skilled Pediatric Care is expected to complete by year-end 2025.
Read more →-AVAH
Oct 21, 2025AVEANNA HEALTHCARE HOLDINGS ANNOUNCES PRELIMINARY THIRD QUARTER FINANCIAL RESULTS Atlanta, Georgia (
Aveanna Healthcare Holdings Inc. announced preliminary financial results for the third quarter of 2025, expecting revenue between $616 million and $624 million, marking an increase of approximately 21.0% to 22.6% compared to the previous year. Projected net income is between $11 million and $15 million, reflecting significant growth of 125.7% to 135.0%. Adjusted EBITDA is anticipated to be approximately $77 million to $81 million, which demonstrates a considerable rise of 61.0% to 69.3%. However, these figures remain preliminary and are subject to change following further financial reviews and consolidation of statements.
Read more →-AVAH
Sep 29, 2025Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute
Aveanna Healthcare Holdings Inc. released an investor presentation detailing disclaimers and forward-looking statements regarding their financial prospects and strategies. The presentation clarifies that the information is for informational purposes only and does not serve as a solicitation for investment. Various factors, including growth strategy execution risks and changes in government regulations, could impact the company's future performance. The document emphasizes that past performance is not indicative of future results and includes non-GAAP measurements to evaluate business performance.
Read more →-AVAH
Sep 18, 2025Aveanna HEALTHCARE ANNOUNCES SUCCESSFUL DEBT REFINANCING Atlanta, Georgia (
Aveanna Healthcare Holdings Inc. announced the successful refinancing of its first lien credit facility, closing a transaction valued at $1.325 billion. This includes the refinancing of existing term loans and an incremental borrowing of $439 million. The refinancing extends the maturity dates of the loans and revolving credit, significantly improving the company's liquidity and financial position. CEO Jeff Shaner highlighted the successful operating performance as a key driver behind this achievement.
Read more →-AVAH
Aug 8, 2025▲ +5.7%on this news· ran to +23% by day 3
Investor Presentation August 2025 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information pu
Aveanna Healthcare Holdings Inc. has released an investor presentation that includes disclaimers regarding the information provided, making it clear that it does not constitute an offer to sell or buy securities. The presentation highlights various forward-looking statements that are uncertain and contingent upon numerous risks, including market conditions and operational performance. It is advised that viewers of the presentation consider these cautionary notes, as actual results may deviate significantly from those suggested in forward-looking statements. Additionally, it emphasizes the reliance on third-party data, which Aveanna has not independently verified.
Read more →-AVAH
Aug 7, 2025▲ +49.4%on this news· ran to +86% by day 3shared move
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND REVISED 2025 OUTLOOK • Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year period • Second Quarter Net
Aveanna Healthcare Holdings announced its financial results for the second quarter of 2025, reporting revenue of $589.6 million, a 16.8% increase over the previous year. Net income also surged by 94.3% to $27.0 million, and adjusted EBITDA increased by 93.6%. The company revised its full-year revenue guidance for 2025 to greater than $2.3 billion, up from $2.15 billion. This reflects the positive momentum across all three operating divisions as the company continues to expand its services and improve operational efficiency.
Read more →-AVAH
Jun 4, 2025AVEANNA HEALTHCARE HOLDINGS COMPLETES ACQUISITION OF THRIVE SKILLED PEDIATRIC CARE Atlanta, Georgia (
Aveanna Healthcare Holdings Inc. has successfully completed its acquisition of Thrive Skilled Pediatric Care, a leading pediatric home care provider with locations in seven states. This strategic move aims to enhance Aveanna's service offerings and market presence while introducing its specialized care model to new areas. Funding for the deal was secured through a combination of cash and stock. The acquisition is expected to provide substantial growth opportunities and strengthen Aveanna's commitment to high-quality care.
Read more →-AVAH
May 9, 2025Investor Presentation May 2025 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information purpo
Aveanna Healthcare Holdings Inc. has released an investor presentation outlining disclaimers and forward-looking statements for May 2025. The presentation clarifies that the information is intended for informational purposes and does not constitute an offer or recommendation to purchase any securities. Forward-looking statements reflect the company's expectations, which involve various risks and uncertainties that could lead to differing actual results. The company emphasizes the importance of understanding the limitations of the data presented, including reliance on third-party sources and the lack of guarantees regarding its accuracy.
Read more →-AVAH
May 8, 2025▲ +14.1%on this newsshared move
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND REVISED 2025 OUTLOOK • First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period o Gross margin increased 25.9%
Aveanna Healthcare Holdings reported strong financial results for the first quarter of 2025, with revenue reaching $559.2 million, reflecting a 14.0% increase year-over-year. The company also noted a notable improvement in adjusted EBITDA, which rose 93.1% compared to the same period in the previous year. Net income turned positive at $5.2 million, up from a net loss of $11.2 million in Q1 2024. Aveanna has updated its guidance for full-year 2025 revenue to be greater than $2.15 billion, signaling a robust outlook amid continued operational momentum.
Read more →-AVAH
Apr 3, 2025▼ -5.3%on this news
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO ACQUIRE THRIVE SKILLED PEDIATRIC CARE Atlanta, Georgia (
Aveanna Healthcare Holdings has announced an agreement to acquire Thrive Skilled Pediatric Care, expanding its services in pediatric home care across multiple states. The acquisition, which is subject to regulatory approvals, aims to strengthen Aveanna's position in delivering high-quality, patient-centered care. CEO Jeff Shaner expressed enthusiasm for the merger, citing shared values and goals between the two organizations. Thrive SPC has a solid reputation in the industry and is expected to enhance Aveanna's service offerings.
Read more →-AVAH
Mar 13, 2025▲ +37.4%on this news
Investor Presentation March 2025 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information pur
Aveanna Healthcare's investor presentation for March 2025 outlines important disclaimers regarding forward-looking statements. The presentation emphasizes that the information provided does not constitute an offer to buy or sell securities and is based on various assumptions that may not hold true. Aveanna cautions that these statements are subject to a significant amount of risk and uncertainty that could lead to actual performance differing materially from the forecasts made. No obligation to update the information is taken on except as required by law.
Read more →-AVAH
Mar 13, 2025▲ +37.4%on this news
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND 2025 OUTLOOK • Fourth Quarter Revenue was $519.9 million, an 8.6% increase over the prior year period o Gross margin in
Aveanna Healthcare Holdings reported strong financial results for Q4 2024, with revenues reaching $519.9 million, representing an 8.6% increase from the previous year. The adjusted EBITDA for the quarter was $55.2 million, marking a 42.8% increase. The company also provided an optimistic outlook for 2025, forecasting revenues between $2.10 - $2.12 billion. These results are seen as a reflection of successful operational strategies and strong market performance.
Read more →-AVAH
Nov 7, 2024▲ +16.2%on this newsshared move
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • Third Quarter Revenue was $509.0 million, a 6.5% increase over the prior year period o Gross margin increased 8
Aveanna Healthcare Holdings announced its third quarter 2024 financial results, reporting a revenue of $509 million, a 6.5% increase from the previous year. Adjusted EBITDA saw a significant rise of 32.2%, highlighting improved operational efficiency and profitability. The company also raised its full year revenue guidance to approximately $2.0 billion, reflecting positive momentum in the business and strategic cost reductions. However, the report also noted a net loss of $42.8 million, although this was an improvement compared to last year's losses.
Read more →-AVAH
Nov 4, 2024AVEANNA HEALTHCARE HOLDINGS ANNOUNCES APPOINTMENT OF NEW DIRECTOR Atlanta, Georgia (
Aveanna Healthcare Holdings Inc. has appointed Brent Layton as a Class III director on its Board of Directors effective November 1, 2024. With over 20 years of leadership experience at Centene Corporation and currently the CEO of Sharecare, Layton is expected to enhance Aveanna's strategic growth. His expertise in healthcare policy and managed care is seen as a valuable asset for the company as it aims to improve its healthcare delivery model. The announcement highlights the company's commitment to building partnerships and enhancing services in the home care sector.
Read more →-AVAH
Oct 4, 2024AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO EXTEND ITS REVOLVING CREDIT FACILITY Atlanta, Georgia (
Aveanna Healthcare Holdings Inc. announced an amendment to its revolving credit facility, extending the maturity date to April 2028 and adjusting the maximum borrowing availability. This move aims to provide additional liquidity to support the company's growth and maintain high-quality care. CFO Matt Buckhalter emphasized the importance of this extension for investments and operational continuity. The company will also report its third-quarter earnings on November 7, 2024.
Read more →-AVAH
Aug 9, 2024Investor Presentation August 2024 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information pu
Aveanna Healthcare Holdings Inc. has released an investor presentation that includes disclaimers and forward-looking statements regarding its financial prospects and growth strategy. The presentation emphasizes that the information provided is for informational purposes only and does not constitute an investment offer. Risks associated with potential acquisitions, performance outcomes, and regulatory changes are highlighted, reminding stakeholders of the uncertainties involved. Additionally, the company specifies that past performance does not guarantee future results.
Read more →-AVAH
Aug 8, 2024▲ +32.2%on this newsshared move
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • Second Quarter Revenue was $505.0 million, a 7.0% increase over the prior year o Gross margin increased 1.9% t
Aveanna Healthcare Holdings announced its financial results for the second quarter of 2024, indicating a revenue increase of 7.0% year-over-year to $505 million. The company also reported a significant growth in Adjusted EBITDA, reaching $45.6 million, up by 27.3%. However, net income decreased compared to the prior year, falling to $13.9 million. Aveanna has raised its full-year revenue and Adjusted EBITDA guidance, reflecting a positive outlook due to strategic improvements and enhanced payer partnerships.
Read more →-AVAH
May 31, 2024Investor Presentation June 2024 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information purp
Aveanna Healthcare Holdings Inc. presented an investor presentation for June 2024, emphasizing the risks associated with forward-looking statements. The document outlines that statements regarding the company's future performance are subject to uncertainties and may differ from actual outcomes. It clearly states that the information provided should not be construed as investment advice and highlights various risks that can impact the company's growth strategy and operational results.
Read more →-AVAH
May 9, 2024AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year o Gross margin increased 1.0% to
Aveanna Healthcare Holdings reported a first quarter revenue of $490.7 million, a 5.2% increase from the previous year. The company's net loss significantly decreased to $11.2 million, down from $32.0 million in the same quarter last year. Adjusted EBITDA rose 22.5% to $34.9 million, prompting the company to raise its full year revenue and Adjusted EBITDA guidance. Despite positive growth indicators, the company still faced challenges with negative operating cash flow.
Read more →-AVAH
Mar 14, 2024AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER 2023 FINANCIAL RESULTS AND 2024 OUTLOOK • Fourth Quarter Revenue was $478.8 million, a 6.1% increase over the prior year o Gross margin increased 15.3% to $148.
Aveanna Healthcare Holdings reported a strong performance for the fourth quarter of 2023, with revenues reaching $478.8 million, a 6.1% increase from the previous year. The company's adjusted EBITDA also rose by 30.4%, highlighting their operational improvements. Despite a net loss of $25.7 million, this marks a significant reduction from the prior year’s $237.8 million loss. For 2024, Aveanna projects revenues between $1,960 million and $1,980 million, alongside an expected adjusted EBITDA of $146 to $150 million.
Read more →-AVAH
Dec 11, 2023▼ -7.3%on this news
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES APPOINTMENT OF CHIEF FINANCIAL OFFICER Atlanta, Georgia (
Aveanna Healthcare Holdings has announced the appointment of Matt Buckhalter as Chief Financial Officer, effective January 1, 2024. Buckhalter, who has been with the company since 2016 and served as Interim CFO since July 2023, is recognized for his strong financial leadership capabilities. The Board of Directors and CEO Jeff Shaner expressed confidence in his ability to guide Aveanna's financial strategies and initiatives moving forward. This appointment aligns with the company’s focus on delivering high-quality care to complex patient populations.
Read more →-AVAH
Nov 9, 2023AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS • Revenue was $478.0 million, a 7.9% increase over the prior year o Gross margin increased 9.4% to $147.3 million, compared to Q3 2022 &#x
Aveanna Healthcare Holdings announced its financial results for the third quarter of 2023, showing a revenue increase to $478.0 million, up 7.9% year-over-year. The company's gross margin improved by 9.4%, reaching $147.3 million. However, Aveanna reported a significant net loss of $102.4 million, attributed to a large non-cash goodwill impairment. The company raised its full-year revenue and Adjusted EBITDA guidance, reflecting confidence in continued growth and operational improvements.
Read more →-AVAH
Aug 10, 2023AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS • Revenue was $471.9 million, a 6.5% increase over the prior year o Gross margin increased 7.0% to $155.3 million, compared to Q2 2022 &#
Aveanna Healthcare Holdings reported strong financial results for the second quarter of 2023, with revenue of $471.9 million, marking a 6.5% increase from the previous year. The company also achieved a net income of $25.6 million, a significant turnaround from a loss of $473.9 million in the same period of 2022. Furthermore, Aveanna has raised its revenue and adjusted EBITDA guidance for the full year 2023, indicating confidence in continued growth. The CEO emphasized the importance of enhanced payor partnerships and investments in caregivers as key drivers of this performance.
Read more →-AVAH
Aug 4, 2023AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO EXTEND ITS $175 MILLION SECURITIZATION FACILITY Atlanta, Georgia (
Aveanna Healthcare Holdings has successfully amended its securitization facility, extending its maturity date to July 31, 2026, while maintaining total availability at $175 million. The company aims to utilize this financial flexibility to invest in its growth strategy focused on value-based care in home health services. Interim CFO Matt Buckhalter expressed confidence in the company's financial position and thanked its credit partners for their support. The company is set to report its second quarter earnings on August 10, 2023.
Read more →-AVAH
Jun 15, 2023▲ +12.9%on this news
Aveanna Announces Resignation of Chief Financial Officer; Announces Corresponding Appointments; Reaffirms FY 2023 Guidance ATLANTA
Aveanna Healthcare announced the resignation of Chief Financial Officer David Afshar, effective July 7, 2023, as he pursues other opportunities. To ensure continuity, Matt Buckhalter has been appointed as Interim CFO, and Debbie Stewart has been promoted to Senior Vice President and Principal Accounting Officer. Despite this leadership change, the company reaffirmed its FY 2023 guidance, expecting a revenue of at least $1,840 million, indicating confidence in its financial outlook.
Read more →-AVAH
May 11, 2023AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS • Revenue increased 3.5% to $466.4 million, compared to Q1 2022 o Gross margin decreased 0.2% to $144.5 million, compared to Q1 2022  
Aveanna Healthcare Holdings reported its financial results for Q1 2023, noting a 3.5% increase in revenue to $466.4 million compared to the same period in 2022. However, the company experienced a net loss of $32 million, a stark contrast to the previous year's net income of $25.3 million. Despite these challenges, management expressed confidence in their operational strategy and affirmed their revenue guidance for the year. Adjusted EBITDA also saw a decline, prompting concerns over cash flow management and operational efficiency.
Read more →-AVAH
Mar 16, 2023▼ -6.7%on this news· ran to -23% by day 3
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS • Revenue increased 9.0% to $451.1 million, compared to Q4 2021 o Gross margin increased 3.5% to $128.8 million, compared t
Aveanna Healthcare Holdings reported Q4 2022 financial results showing a revenue increase to $451.1 million, up 9% from Q4 2021. Gross margin improved to $128.8 million, although the net loss widened to $237.8 million, reflecting substantial non-cash impairment charges. CEO Jeff Shaner noted expectations for improved reimbursement rates and caregiver retention, while CFO David Afshar expressed optimism about liquidity in 2023 despite challenges in the economic environment.
Read more →-AVAH
Dec 13, 2022AVEANNA HEALTHCARE HOLDINGS ANNOUNCES CEO TRANSITION AND REAFFIRMS FY 2022 REVENUE AND ADJUSTED EBITDA GUIDANCE Atlanta, Georgia (
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES REAFFIRMS FY 2022 REVENUE AND ADJUSTED EBITDA GUIDANCE Atlanta, Georgia (December 13, 2022) Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-co
Read more →-AVAH
Nov 9, 2022▼ -5.4%on this news
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD-QUARTER 2022 FINANCIAL RESULTS Atlanta, Georgia (
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD-QUARTER 2022 FINANCIAL RESULTS Atlanta, Georgia (November 9, 2022) Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populatio
Read more →-AVAH
Aug 10, 2022AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND-QUARTER 2022 FINANCIAL RESULTS Atlanta, Georgia (
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND-QUARTER 2022 FINANCIAL RESULTS Atlanta, Georgia (August 10, 2022) Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populatio
Read more →-AVAH
Jul 19, 2022▼ -9.8%on this news· ran to -21% by day 3
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES PRELIMINARY SECOND QUARTER 2022 RESULTS UPDATED FULL-YEAR 2022 GUIDANCE & EARNINGS RELEASE DATE Atlanta, Georgia (
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES PRELIMINARY SECOND QUARTER 2022 RESULTS UPDATED FULL-YEAR 2022 GUIDANCE & EARNINGS RELEASE DATE Atlanta, Georgia (July 19, 2022) Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providin
Read more →-AVAH
May 11, 2022▼ -6.5%on this news
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST-QUARTER 2022 FINANCIAL RESULTS • Revenue increased 8.0% to $450.5 million, compared to Q1 2021 • Acquisitions of Comfort Care (HHH) and Accredited (PDS) drove rev
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST-QUARTER 2022 FINANCIAL RESULTS -Revenue increased 8.0% to $450.5 million, compared to Q1 2021 -Acquisitions of Comfort Care (HHH) and Accredited (PDS) drove revenue growth -Gross margin increased 10.0% to $144.8 million, compared to
Read more →-AVAH
Apr 27, 2022Disclaimers and Forward-Looking Statements This investor presentation (this presentation and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer
Investor Presentation April 27, 2022 Exhibit 99.1 Disclaimers and Forward-Looking Statements This investor presentation (this presentation and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell,
Read more →-AVAH
Mar 28, 2022AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS • Fiscal year 2021 revenue increased 12.3% to $1,678.6 million, compared to fiscal year 2020 • Fiscal year 2021 had
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS -Fiscal year 2021 revenue increased 12.3% to $1,678.6 million, compared to fiscal year 2020 -Fiscal year 2021 had 52 weeks compared to 53 weeks in 2020; Q4 2021 had 13 weeks compared to 1
Read more →-AVAH
Nov 15, 2021AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD-QUARTER 2021 FINANCIAL RESULTS Third Quarter 2021 Highlights  Revenue Increased 12.4% to $411.3 Million  Gross Margin Increased 22.4% to $139.7 Million 
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD-QUARTER 2021 FINANCIAL RESULTS Third Quarter 2021 Highlights Revenue Increased 12.4% to $411.3 Million Gross Margin Increased 22.4% to $139.7 Million Net Income of $2.1 Million, or $0.01 per Diluted Share Adjusted Net Income per D
Read more →-AVAH
Aug 11, 2021AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND-QUARTER 2021 FINANCIAL RESULTS Revenue Increased 24.0% to $436.1 Million Gross Margin Increased 37.5% to $146.6 Million Net Income of $1.3 Million, or $0.01 per Diluted Share
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND-QUARTER 2021 FINANCIAL RESULTS Revenue Increased 24.0% to $436.1 Million Gross Margin Increased 37.5% to $146.6 Million Net Income of $1.3 Million, or $0.01 per Diluted Share Adjusted Net Income per Diluted Share of $0.10 Adjuste
Read more →-AVAH
May 25, 2021AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST-QUARTER 2021 FINANCIAL RESULTS Revenue Increased 17.4% to $417.2 Million Gross Margin Increased 22.4% to $131.7 Million Net Income of $5.8 Million, or $0.04 per Diluted Share A
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST-QUARTER 2021 FINANCIAL RESULTS Revenue Increased 17.4% to $417.2 Million Gross Margin Increased 22.4% to $131.7 Million Net Income of $5.8 Million, or $0.04 per Diluted Share Adjusted Net Income per Diluted Share of $0.08 Adjusted
Read more →Competitive Position
How AVAH ranks across every disease it competes inCompetitive Position is a premium feature
See how AVAH ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial